- Home
- BOWL vs VERA Comparison
BOWL vs VERA Comparison
Compare BOWL & VERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BOWL
- VERA
- Stock Information
- Founded
- BOWL 1900
- VERA 2016
- Country
- BOWL United States
- VERA United States
- Employees
- BOWL N/A
- VERA N/A
- Industry
- BOWL Services-Misc. Amusement & Recreation
- VERA Biotechnology: Pharmaceutical Preparations
- Sector
- BOWL Consumer Discretionary
- VERA Health Care
- Exchange
- BOWL Nasdaq
- VERA Nasdaq
- Market Cap
- BOWL 1.6B
- VERA 2.5B
- IPO Year
- BOWL N/A
- VERA 2021
- Fundamental
- Price
- BOWL $10.82
- VERA $42.01
- Analyst Decision
- BOWL Strong Buy
- VERA Strong Buy
- Analyst Count
- BOWL 9
- VERA 9
- Target Price
- BOWL $16.00
- VERA $53.56
- AVG Volume (30 Days)
- BOWL 366.9K
- VERA 683.6K
- Earning Date
- BOWL 11-04-2024
- VERA 11-07-2024
- Dividend Yield
- BOWL 1.91%
- VERA N/A
- EPS Growth
- BOWL N/A
- VERA N/A
- EPS
- BOWL N/A
- VERA N/A
- Revenue
- BOWL $1,154,614,000.00
- VERA N/A
- Revenue This Year
- BOWL $9.73
- VERA N/A
- Revenue Next Year
- BOWL $7.42
- VERA N/A
- P/E Ratio
- BOWL N/A
- VERA N/A
- Revenue Growth
- BOWL 9.05
- VERA N/A
- 52 Week Low
- BOWL $8.85
- VERA $9.68
- 52 Week High
- BOWL $15.47
- VERA $50.78
- Technical
- Relative Strength Index (RSI)
- BOWL 42.52
- VERA 52.57
- Support Level
- BOWL $11.15
- VERA $39.22
- Resistance Level
- BOWL $11.79
- VERA $50.00
- Average True Range (ATR)
- BOWL 0.43
- VERA 2.41
- MACD
- BOWL -0.09
- VERA 0.24
- Stochastic Oscillator
- BOWL 3.99
- VERA 28.53
About BOWL Bowlero Corp.
Bowlero Corp is a operator of bowling entertainment centers. It operate traditional bowling centers and more upscale entertainment concepts with lounge seating, arcades, enhanced food and beverage offerings, and more robust customer service for individuals and group events, as well as hosting and overseeing professional and non-professional bowling tournaments and related broadcasting.
About VERA Vera Therapeutics Inc.
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.